Shortly after 7am on Christmas Eve, Christie Pitronaci woke up, dying. She had no feeling on one side of her body and could not speak. She was choking. Christie Pitronaci with her daughter Mia.

Jupiter Endovascular completes enrollment in a pivotal trial of its Vertex system with Transforming Fixation technology for pulmonary embolectomy.

Often relegated to the second or third tier of treatment options, surgical management of patients with massive or high-risk submassive acute pulmonary embolism (PE)—either with embolectomy or ...

Tissue plasminogen activator can improve neurologic outcome after acute ischemic stroke (AIS); however, as an intravenous or catheter-based treatment strategy, it is not suitable for all AIS patients.

Jupiter Endovascular announced that it completed patient enrollment in the SPIRARE II pivotal clinical trial evaluating its Vertex system.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Add articles to your saved list and come back to them any time. Shortly after 7am on Christmas Eve, Christie Pitronaci woke up, dying. She had no feeling on one side of her body and could not speak.